Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp

Bullboard Posts

Post by 3woodon Sep 23, 2008 11:29am

1011 Views

Post# 15477956

Rumor

Does anyone know why the SP has a buck 50 swings almost daily ? I haven't talked to any of DM's family so I don't what the rumor mill is doing. It seems dishononorable to use family to spread false facts - taking advantage of those you grew up with is just wrong. I sure would like to see DM state some honest facts with timelines so we could make up our own mind if the wait is worth it.

Bullboard Posts

Paramount Resources signs $3.32 billion asset sale